IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ADAMO, Marianna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.426
AS - Asia 1.755
EU - Europa 1.734
SA - Sud America 12
AF - Africa 9
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 6.950
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.403
SG - Singapore 631
IT - Italia 465
HK - Hong Kong 431
CN - Cina 348
DE - Germania 328
TR - Turchia 251
FI - Finlandia 238
IE - Irlanda 165
GB - Regno Unito 159
UA - Ucraina 138
CZ - Repubblica Ceca 55
RU - Federazione Russa 38
IN - India 37
SE - Svezia 35
FR - Francia 29
BE - Belgio 23
CA - Canada 20
JP - Giappone 16
NL - Olanda 15
ES - Italia 11
AU - Australia 7
IR - Iran 7
KR - Corea 7
ID - Indonesia 6
PL - Polonia 6
AT - Austria 4
BR - Brasile 4
EU - Europa 4
PH - Filippine 4
TW - Taiwan 4
AR - Argentina 3
EG - Egitto 3
GR - Grecia 3
SA - Arabia Saudita 3
VN - Vietnam 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CH - Svizzera 2
HR - Croazia 2
HU - Ungheria 2
LU - Lussemburgo 2
LV - Lettonia 2
MX - Messico 2
NZ - Nuova Zelanda 2
PE - Perù 2
SI - Slovenia 2
TN - Tunisia 2
VE - Venezuela 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CL - Cile 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
MY - Malesia 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
Totale 6.950
Salva come PNG Salva come JPEG
Città #
Singapore 495
Chandler 449
Hong Kong 427
Fairfield 364
Ashburn 266
Princeton 238
Istanbul 237
Helsinki 199
Beijing 175
Houston 169
Dublin 165
Woodbridge 165
Seattle 154
Wilmington 139
New York 138
Cambridge 130
Jacksonville 116
Romola 89
Ann Arbor 73
Shanghai 68
Milan 61
Brno 44
Brescia 37
Lappeenranta 34
Frankfurt am Main 33
London 30
Los Angeles 30
Munich 30
San Diego 29
Des Moines 27
Pune 24
Brussels 23
Brindisi 19
Rome 16
Nanjing 15
Prevalle 15
Kilburn 14
Washington 14
Olomouc 9
San Francisco 9
Strasbourg 9
Tokyo 9
Toronto 9
Changsha 8
Chicago 8
Chiswick 8
West Jordan 8
Acton 7
Boardman 7
Jiaxing 7
Shenyang 7
Bari 6
Nanchang 6
North York 6
Prescot 6
Stockholm 6
Trieste 6
Venice 6
Dearborn 5
Falkenstein 5
Haikou 5
Hebei 5
Jinan 5
Kocaeli 5
New Bedfont 5
Zhengzhou 5
Amsterdam 4
Augusta 4
Curno 4
Gangnam-gu 4
Jakarta 4
Melbourne 4
Nürnberg 4
Padova 4
Taipei 4
Vienna 4
Warsaw 4
A Coruña 3
Airola 3
Azzano San Paolo 3
Berlin 3
Bologna 3
Canberra 3
Edinburgh 3
Guangzhou 3
Hanover 3
Hounslow 3
Kulgam 3
Kunming 3
Lancaster 3
Lviv 3
Madrid 3
Marburg 3
Matera 3
Miami 3
Moscow 3
Nantes 3
Norwalk 3
Potsdam 3
Quezon City 3
Totale 5.051
Salva come PNG Salva come JPEG
Nome #
May 2020 at a glance: ischaemic heart failure and sex-related differences 212
Effectiveness of MitraClip therapy in patients with refractory heart failure 151
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 146
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 145
Self-expanding transcatheter aortic valve implantation for degenerated small Mitroflow bioprosthesis: Early and midterm outcomes 143
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 136
EkoSonic Endovascular System for patients with acute pulmonary embolism and contraindication to systemic fibrinolysis 108
August 2020 at a glance: focus on neurohormonal antagonists and electrolytes 103
January 2020 at a glance: translational medicine, predictors of outcome and treatments 81
September 2019 at a glance: focus on devices 79
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 79
Role of different vascular approaches on transcatheter aortic valve implantation outcome: a single-center study. 76
Trans-axillary versus trans - aortic approach for transcatheter aortic valve implantation with corevalve revalving system: insights from multicenter experience 74
Highlights in heart failure 67
December 2019 at a glance: economic burden, co-morbidities, and prognosis 64
Life-saving transcatheter aortic valve implantation for acute severe aortic regurgitation due to rheumatoid arthritis and complicated by cardiogenic shock 63
Interaction between severe chronic kidney disease and acute kidney injury in predicting mortality after transcatheter aortic valve implantation: Insights from the Italian Clinical Service Project 63
Highlights in valvular heart diseases 62
Role of nutrition in heart failure patients 60
Prognostic Impact of Heart Failure History in Patients with Secondary Mitral Regurgitation Treated by MitraClip 59
Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials? 58
April 2020 at a glance: epidemiology, prevention, and biomarkers 58
COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease 57
Impact of disproportionate secondary mitral regurgitation in patients undergoing edge-to-edge percutaneous mitral valve repair 56
October 2019 at a glance: epidemiology, prevention, and modes of death 56
Percutaneous treatment of mitral regurgitation: looking for a final model 54
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 54
ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19 54
COAPT-Like Profile Predicts Long-Term Outcomes in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation 53
Percutaneous valve repair of functional mitral regurgitation: aiming at optimal and durable results 52
November 2019 at a glance. Chronic and acute heart failure: from epidemiology to treatment 52
Transcatheter therapies for tricuspid valve regurgitation 52
Prognostic Value of Pre-operative Atrial Fibrillation in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation 50
Atrial fibrillation in the COVID-19 era: Simple bystander or marker of increased risk? 49
February 2020 at a glance: acute heart failure and cardio-oncology 45
Il dronedarone: in quali pazienti e con quali associazioni? 44
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 43
Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology 43
Renal failure after trans-catheter aortic valve implantation 42
Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials 42
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors 40
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC 40
September 2020 at a glance: focus on heart failure with preserved ejection fraction and medical therapy 40
July 2020 at a glance: focus on imaging and cardiomyopathies 40
Prognostic value of right ventricle to pulmonary artery coupling in transcatheter aortic valve implantation recipients 39
A Score to Assess Mortality After Percutaneous Mitral Valve Repair 38
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 38
Right ventricular deformation and right ventricular-arterial coupling in patients with heart failure due to severe aortic stenosis undergoing TAVI: long-term results. 38
A meta-analysis of MitraClip combined with medical therapy vs. medical therapy alone for treatment of mitral regurgitation in heart failure patients 38
Patient with heart failure: importance to treat valvular diseases 37
Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair: Insights from the multicenter GRASP-IT registry 36
APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: The APACHE pilot study 36
Prediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score 35
March 2020 at a glance: heart failure with preserved ejection fraction, left atrial myopathy, atrial fibrillation and cardiac amyloidosis 35
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 34
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 34
Assessment of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing bivalirudin versus unfractionated heparin infusion: The MATRIX (minimizing adverse hemorrhagic events by transradial access site and angioX) OCT study 34
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 33
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC 33
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 33
Reply: Explaining differing outcomes from the COAPT and MITRA-FR trials using disproportionate and proportionate secondary mitral regurgitation 33
Heart failure in the last year: progress and perspective 32
Bioequivalence and excipients: the case of tirofiban. A warning from the Italian Society of Interventional Cardiology (SICI-GISE) | [Bioequivalenza ed eccipienti: il caso del tirofiban. Un “warning” della Società Italiana di Cardiologia Interventistica (SICI-GISE)] 32
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 32
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 32
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 31
[Advances in heart failure treatment: a summary of 50 years of evolution] 31
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage] 30
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 30
Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: Results of an EAPCI survey 30
Percutaneous Edge-to-Edge Mitral Valve Repair: Beyond the Left Heart 30
Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy 29
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? A Pre-Specified Analysis from the ZEUS Trial 29
March 2023 at a glance: pathophysiology, medical therapy and devices 28
Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation: A Patient-Level, Multicenter Analysis 28
Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction 28
Updates in heart failure: sodium glucose co-transporter 2 inhibitors and beyond - major changes are coming 28
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 27
Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial 27
Transcatheter Edge-to-Edge Repair in COAPT-Ineligible Patients: Incidence and Predictors of 2-Year Good Outcome 27
Impact of Transcatheter Edge-to-Edge Mitral Valve Repair on Guideline-Directed Medical Therapy Uptitration 26
COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae 26
Direct transcatheter aortic valve implantation with self-expandable bioprosthesis: Feasibility and safety 26
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part I: From cardiovascular risk factors to the mechanisms of cardio-renal syndrome] 25
April 2022 at a glance: focus on prevention, acute heart failure and heart failure with preserved ejection fraction 25
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 25
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure 25
Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion 25
Long-term outcomes after transcatheter aortic valve replacement in nonagenarians: a multicenter age-based analysis 25
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF 25
Observed versus predicted mortality after MitraClip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation 25
Does smoking habit affect the randomized comparison of 6 versus 24-month dual antiplatelet therapy duration? Insights from the PRODIGY trial 25
April 2021 at a glance: focus on systolic function, quality of life and treatment in heart failure 25
[Sodium-glucose cotransporter 2 inhibitors and heart failure with preserved ejection fraction: the EMPEROR-Preserved and DELIVER studies] 24
Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry) 24
Antithrombotic and anticoagulation therapies in cardiogenic shock: a critical review of the published literature 24
Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation 24
August 2021 at a glance: focus on cardiomyopathies, medical treatment and devices 24
[Transcatheter devices for chronic heart failure: state of the art] 24
Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction 24
Totale 4.806
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.422
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.422
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020345 0 0 0 0 26 48 42 50 31 76 38 34
2020/20211.091 77 145 44 141 41 75 162 102 71 118 71 44
2021/2022728 23 102 22 83 21 57 15 76 34 51 42 202
2022/20231.347 150 48 20 115 101 377 10 144 201 19 85 77
2023/20242.078 111 39 174 150 117 243 144 62 502 79 81 376
2024/20251.275 46 47 185 502 495 0 0 0 0 0 0 0
Totale 7.196